 | • レポートコード：D0GIR-09381 • 出版社/出版日：GlobalInfoResearch / 2020年9月23日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、134ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、豚繁殖・呼吸障害症候群（PRRS）ワクチンの世界市場を広く調査・分析し、今後の市場展望をまとめております。豚繁殖・呼吸障害症候群（PRRS）ワクチンの種類別市場規模（生ワクチン、不活化ワクチン）、用途別市場規模（政府、マーケティング）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：CNADC、Qilu Animal Health、Sinopharm、Boehringer-Ingelheim、Tianjin Ruipu Biological Technology Co., Ltd.、MSD Animal Health、CAVAC、Chengdu Tianbang Biological Products Co., Ltd.、Ceva、Guangdong Wens Dahuanong Biotechnology Co., Ltd.、Phibro Animal Health、Guangdong Yongshun Biological Pharmaceutical Co Ltd、Komipharm、Tiankang、Jinyu Bio-Technology、Agrovet、Plec Bioengineering Co., Ltd.、Zoetis、Bioveta ・地域別グローバル市場分析 2015年-2020年 ・豚繁殖・呼吸障害症候群（PRRS）ワクチンの北米市場（アメリカ、カナダ、メキシコ） ・豚繁殖・呼吸障害症候群（PRRS）ワクチンのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・豚繁殖・呼吸障害症候群（PRRS）ワクチンのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・豚繁殖・呼吸障害症候群（PRRS）ワクチンの南米市場（ブラジル、アルゼンチン） ・豚繁殖・呼吸障害症候群（PRRS）ワクチンの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：生ワクチン、不活化ワクチン ・用途別分析：政府、マーケティング ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The most likely (base case) scenario is that the global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) sales will be xx in 2020 from Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) million in 2019, with a change xx% between 2019 and 2020. In addition, based on the latest study, it is to predict that the Covid-19 will be under control in key countries like the United States, Western Europe, East Asia, by the end of Q2 (June), and will resume normal production in Q3 and Q4, the global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) market size is expected to grow at xx% or more annually for the next five years.
This report also researches and evaluates the impact of Covid-19 outbreak on the Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).
Market segmentation
Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) market has been segmented into
Live Vaccine
Inactivated Vaccine
By Application, Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) has been segmented into:
Government Tender
Marketing
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) market presented in the report. This section sheds light on the sales growth of different regional and country-level Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) market.
The report offers in-depth assessment of the growth and other aspects of the Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Share Analysis
Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) sales, revenue and market share for each player covered in this report.
The major players covered in Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) are:
CNADC
Qilu Animal Health
Sinopharm
Boehringer-Ingelheim
Tianjin Ruipu Biological Technology Co., Ltd.
MSD Animal Health
CAVAC
Chengdu Tianbang Biological Products Co., Ltd.
Ceva
Guangdong Wens Dahuanong Biotechnology Co., Ltd.
Phibro Animal Health
Guangdong Yongshun Biological Pharmaceutical Co Ltd
Komipharm
Tiankang
Jinyu Bio-Technology
Agrovet
Plec Bioengineering Co., Ltd.
Zoetis
Bioveta
Among other players domestic and global, Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS), with price, sales, revenue and global market share of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) in 2018 and 2019.
Chapter 3, the Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Live Vaccine
1.2.3 Inactivated Vaccine
1.3 Market Analysis by Application
1.3.1 Overview: Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Government Tender
1.3.3 Marketing
1.4 Overview of Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market
1.4.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
1.6 COVID-19 Outbreak: Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Industry Impact
1.6.1 COVID-19 Potential Implications for the Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS)
1.6.1.1 Scenario One: Very Optimistic: COVID-19 has No Influence on Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS)
1.6.1.2 Scenario Two: Optimistic: COVID-19 Will Be Under Control by the End of April
1.6.1.3 Scenario Three: Gloomy: COVID-19 Will Be Under Control Between Q3 and Q4
1.6.1.4 Scenario Four: Most Likely: COVID-19 Will Be Under Control by the End of Q2
1.6.2 Opportunity Analysis in Covid-19 Crisis
1.6.3 Market Risk and Restraints
1.6.4 Market Driving Force
2 Manufacturers Profiles
2.1 CNADC
2.1.1 CNADC Details
2.1.2 CNADC Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 CNADC SWOT Analysis
2.1.4 CNADC Product and Services
2.1.5 CNADC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Qilu Animal Health
2.2.1 Qilu Animal Health Details
2.2.2 Qilu Animal Health Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Qilu Animal Health SWOT Analysis
2.2.4 Qilu Animal Health Product and Services
2.2.5 Qilu Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Sinopharm
2.3.1 Sinopharm Details
2.3.2 Sinopharm Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Sinopharm SWOT Analysis
2.3.4 Sinopharm Product and Services
2.3.5 Sinopharm Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Boehringer-Ingelheim
2.4.1 Boehringer-Ingelheim Details
2.4.2 Boehringer-Ingelheim Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Boehringer-Ingelheim SWOT Analysis
2.4.4 Boehringer-Ingelheim Product and Services
2.4.5 Boehringer-Ingelheim Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Tianjin Ruipu Biological Technology Co., Ltd.
2.5.1 Tianjin Ruipu Biological Technology Co., Ltd. Details
2.5.2 Tianjin Ruipu Biological Technology Co., Ltd. Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Tianjin Ruipu Biological Technology Co., Ltd. SWOT Analysis
2.5.4 Tianjin Ruipu Biological Technology Co., Ltd. Product and Services
2.5.5 Tianjin Ruipu Biological Technology Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 MSD Animal Health
2.6.1 MSD Animal Health Details
2.6.2 MSD Animal Health Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 MSD Animal Health SWOT Analysis
2.6.4 MSD Animal Health Product and Services
2.6.5 MSD Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 CAVAC
2.7.1 CAVAC Details
2.7.2 CAVAC Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 CAVAC SWOT Analysis
2.7.4 CAVAC Product and Services
2.7.5 CAVAC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Chengdu Tianbang Biological Products Co., Ltd.
2.8.1 Chengdu Tianbang Biological Products Co., Ltd. Details
2.8.2 Chengdu Tianbang Biological Products Co., Ltd. Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Chengdu Tianbang Biological Products Co., Ltd. SWOT Analysis
2.8.4 Chengdu Tianbang Biological Products Co., Ltd. Product and Services
2.8.5 Chengdu Tianbang Biological Products Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Ceva
2.9.1 Ceva Details
2.9.2 Ceva Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Ceva SWOT Analysis
2.9.4 Ceva Product and Services
2.9.5 Ceva Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Guangdong Wens Dahuanong Biotechnology Co., Ltd.
2.10.1 Guangdong Wens Dahuanong Biotechnology Co., Ltd. Details
2.10.2 Guangdong Wens Dahuanong Biotechnology Co., Ltd. Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Guangdong Wens Dahuanong Biotechnology Co., Ltd. SWOT Analysis
2.10.4 Guangdong Wens Dahuanong Biotechnology Co., Ltd. Product and Services
2.10.5 Guangdong Wens Dahuanong Biotechnology Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Phibro Animal Health
2.11.1 Phibro Animal Health Details
2.11.2 Phibro Animal Health Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Phibro Animal Health SWOT Analysis
2.11.4 Phibro Animal Health Product and Services
2.11.5 Phibro Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Guangdong Yongshun Biological Pharmaceutical Co Ltd
2.12.1 Guangdong Yongshun Biological Pharmaceutical Co Ltd Details
2.12.2 Guangdong Yongshun Biological Pharmaceutical Co Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Guangdong Yongshun Biological Pharmaceutical Co Ltd SWOT Analysis
2.12.4 Guangdong Yongshun Biological Pharmaceutical Co Ltd Product and Services
2.12.5 Guangdong Yongshun Biological Pharmaceutical Co Ltd Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 Komipharm
2.13.1 Komipharm Details
2.13.2 Komipharm Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Komipharm SWOT Analysis
2.13.4 Komipharm Product and Services
2.13.5 Komipharm Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.14 Tiankang
2.14.1 Tiankang Details
2.14.2 Tiankang Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Tiankang SWOT Analysis
2.14.4 Tiankang Product and Services
2.14.5 Tiankang Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.15 Jinyu Bio-Technology
2.15.1 Jinyu Bio-Technology Details
2.15.2 Jinyu Bio-Technology Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Jinyu Bio-Technology SWOT Analysis
2.15.4 Jinyu Bio-Technology Product and Services
2.15.5 Jinyu Bio-Technology Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.16 Agrovet
2.16.1 Agrovet Details
2.16.2 Agrovet Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 Agrovet SWOT Analysis
2.16.4 Agrovet Product and Services
2.16.5 Agrovet Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.17 Plec Bioengineering Co., Ltd.
2.17.1 Plec Bioengineering Co., Ltd. Details
2.17.2 Plec Bioengineering Co., Ltd. Major Business and Total Revenue (Financial Highlights) Analysis
2.17.3 Plec Bioengineering Co., Ltd. SWOT Analysis
2.17.4 Plec Bioengineering Co., Ltd. Product and Services
2.17.5 Plec Bioengineering Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.18 Zoetis
2.18.1 Zoetis Details
2.18.2 Zoetis Major Business and Total Revenue (Financial Highlights) Analysis
2.18.3 Zoetis SWOT Analysis
2.18.4 Zoetis Product and Services
2.18.5 Zoetis Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.19 Bioveta
2.19.1 Bioveta Details
2.19.2 Bioveta Major Business and Total Revenue (Financial Highlights) Analysis
2.19.3 Bioveta SWOT Analysis
2.19.4 Bioveta Product and Services
2.19.5 Bioveta Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Manufacturer Market Share in 2019
3.3.2 Top 6 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Market Share by Regions
4.1.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales and Market Share by Regions (2015-2020)
4.1.2 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue and Market Share by Regions (2015-2020)
4.2 North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales and Growth Rate (2015-2020)
4.3 Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales and Growth Rate (2015-2020)
4.5 South America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Market Share by Country
5.1.1 North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales and Market Share by Country (2015-2020)
5.1.2 North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue and Market Share by Country (2015-2020)
5.2 United States Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales and Growth Rate (2015-2020)
5.3 Canada Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales and Growth Rate (2015-2020)
5.4 Mexico Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Market Share by Country
6.1.1 Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales and Market Share by Country (2015-2020)
6.1.2 Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue and Market Share by Country (2015-2020)
6.2 Germany Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales and Growth Rate (2015-2020)
6.3 UK Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales and Growth Rate (2015-2020)
6.4 France Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales and Growth Rate (2015-2020)
6.5 Russia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales and Growth Rate (2015-2020)
6.6 Italy Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue and Market Share by Regions (2015-2020)
7.2 China Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales and Growth Rate (2015-2020)
7.3 Japan Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales and Growth Rate (2015-2020)
7.4 Korea Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales and Growth Rate (2015-2020)
7.5 India Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales and Growth Rate (2015-2020)
7.7 Australia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Market Share by Country
8.1.1 South America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales and Market Share by Country (2015-2020)
8.1.2 South America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue and Market Share by Country (2015-2020)
8.2 Brazil Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales and Growth Rate (2015-2020)
8.3 Argentina Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales and Growth Rate (2015-2020)
9.3 Turkey Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales and Growth Rate (2015-2020)
9.4 Egypt Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales and Growth Rate (2015-2020)
9.5 South Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales and Market Share by Type (2015-2020)
10.2 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue and Market Share by Type (2015-2020)
10.3 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Price by Type (2015-2020)
11 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Segment by Application
11.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Application (2015-2020)
11.2 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Application (2015-2020)
11.3 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Price by Application (2015-2020)
12 Market Forecast
12.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Growth Rate (2021-2025)
12.2 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Forecast by Regions (2021-2025)
12.2.1 North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Forecast (2021-2025)
12.2.2 Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Forecast (2021-2025)
12.2.3 Asia-Pacific Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Forecast (2021-2025)
12.2.4 South America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Forecast (2021-2025)
12.2.5 Middle East & Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Forecast (2021-2025)
12.3 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Forecast by Type (2021-2025)
12.3.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Forecast by Type (2021-2025)
12.3.2 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Share Forecast by Type (2021-2025)
12.4 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Forecast by Application (2021-2025)
12.4.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Forecast by Application (2021-2025)
12.4.2 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size and Growth Estimation in Various Scenarios in 2020
Table 4. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 5. Market Opportunities in Next Few Years
Table 6. Market Risks Analysis
Table 7. Market Drivers
Table 8. CNADC Basic Information, Manufacturing Base and Competitors
Table 9. CNADC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Major Business
Table 10. CNADC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Total Revenue (USD Million) (2018-2019)
Table 11. CNADC SWOT Analysis
Table 12. CNADC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product and Services
Table 13. CNADC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 14. Qilu Animal Health Basic Information, Manufacturing Base and Competitors
Table 15. Qilu Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Major Business
Table 16. Qilu Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Total Revenue (USD Million) (2018-2019)
Table 17. Qilu Animal Health SWOT Analysis
Table 18. Qilu Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product and Services
Table 19. Qilu Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 20. Sinopharm Basic Information, Manufacturing Base and Competitors
Table 21. Sinopharm Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Major Business
Table 22. Sinopharm Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Total Revenue (USD Million) (2018-2019)
Table 23. Sinopharm SWOT Analysis
Table 24. Sinopharm Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product and Services
Table 25. Sinopharm Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 26. Boehringer-Ingelheim Basic Information, Manufacturing Base and Competitors
Table 27. Boehringer-Ingelheim Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Major Business
Table 28. Boehringer-Ingelheim Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Total Revenue (USD Million) (2018-2019)
Table 29. Boehringer-Ingelheim SWOT Analysis
Table 30. Boehringer-Ingelheim Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product and Services
Table 31. Boehringer-Ingelheim Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 32. Tianjin Ruipu Biological Technology Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 33. Tianjin Ruipu Biological Technology Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Major Business
Table 34. Tianjin Ruipu Biological Technology Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Total Revenue (USD Million) (2018-2019)
Table 35. Tianjin Ruipu Biological Technology Co., Ltd. SWOT Analysis
Table 36. Tianjin Ruipu Biological Technology Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product and Services
Table 37. Tianjin Ruipu Biological Technology Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 38. MSD Animal Health Basic Information, Manufacturing Base and Competitors
Table 39. MSD Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Major Business
Table 40. MSD Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Total Revenue (USD Million) (2018-2019)
Table 41. MSD Animal Health SWOT Analysis
Table 42. MSD Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product and Services
Table 43. MSD Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 44. CAVAC Basic Information, Manufacturing Base and Competitors
Table 45. CAVAC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Major Business
Table 46. CAVAC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Total Revenue (USD Million) (2018-2019)
Table 47. CAVAC SWOT Analysis
Table 48. CAVAC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product and Services
Table 49. CAVAC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 50. Chengdu Tianbang Biological Products Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 51. Chengdu Tianbang Biological Products Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Major Business
Table 52. Chengdu Tianbang Biological Products Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Total Revenue (USD Million) (2018-2019)
Table 53. Chengdu Tianbang Biological Products Co., Ltd. SWOT Analysis
Table 54. Chengdu Tianbang Biological Products Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product and Services
Table 55. Chengdu Tianbang Biological Products Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 56. Ceva Basic Information, Manufacturing Base and Competitors
Table 57. Ceva Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Major Business
Table 58. Ceva Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Total Revenue (USD Million) (2018-2019)
Table 59. Ceva SWOT Analysis
Table 60. Ceva Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product and Services
Table 61. Ceva Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 62. Guangdong Wens Dahuanong Biotechnology Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 63. Guangdong Wens Dahuanong Biotechnology Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Major Business
Table 64. Guangdong Wens Dahuanong Biotechnology Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Total Revenue (USD Million) (2018-2019)
Table 65. Guangdong Wens Dahuanong Biotechnology Co., Ltd. SWOT Analysis
Table 66. Guangdong Wens Dahuanong Biotechnology Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product and Services
Table 67. Guangdong Wens Dahuanong Biotechnology Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 68. Phibro Animal Health Basic Information, Manufacturing Base and Competitors
Table 69. Phibro Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Major Business
Table 70. Phibro Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Total Revenue (USD Million) (2018-2019)
Table 71. Phibro Animal Health SWOT Analysis
Table 72. Phibro Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product and Services
Table 73. Phibro Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 74. Guangdong Yongshun Biological Pharmaceutical Co Ltd Basic Information, Manufacturing Base and Competitors
Table 75. Guangdong Yongshun Biological Pharmaceutical Co Ltd Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Major Business
Table 76. Guangdong Yongshun Biological Pharmaceutical Co Ltd Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Total Revenue (USD Million) (2018-2019)
Table 77. Guangdong Yongshun Biological Pharmaceutical Co Ltd SWOT Analysis
Table 78. Guangdong Yongshun Biological Pharmaceutical Co Ltd Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product and Services
Table 79. Guangdong Yongshun Biological Pharmaceutical Co Ltd Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 80. Komipharm Basic Information, Manufacturing Base and Competitors
Table 81. Komipharm Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Major Business
Table 82. Komipharm Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Total Revenue (USD Million) (2018-2019)
Table 83. Komipharm SWOT Analysis
Table 84. Komipharm Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product and Services
Table 85. Komipharm Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 86. Tiankang Basic Information, Manufacturing Base and Competitors
Table 87. Tiankang Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Major Business
Table 88. Tiankang Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Total Revenue (USD Million) (2018-2019)
Table 89. Tiankang SWOT Analysis
Table 90. Tiankang Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product and Services
Table 91. Tiankang Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 92. Jinyu Bio-Technology Basic Information, Manufacturing Base and Competitors
Table 93. Jinyu Bio-Technology Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Major Business
Table 94. Jinyu Bio-Technology Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Total Revenue (USD Million) (2018-2019)
Table 95. Jinyu Bio-Technology SWOT Analysis
Table 96. Jinyu Bio-Technology Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product and Services
Table 97. Jinyu Bio-Technology Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 98. Agrovet Basic Information, Manufacturing Base and Competitors
Table 99. Agrovet Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Major Business
Table 100. Agrovet Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Total Revenue (USD Million) (2018-2019)
Table 101. Agrovet SWOT Analysis
Table 102. Agrovet Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product and Services
Table 103. Agrovet Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 104. Plec Bioengineering Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 105. Plec Bioengineering Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Major Business
Table 106. Plec Bioengineering Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Total Revenue (USD Million) (2018-2019)
Table 107. Plec Bioengineering Co., Ltd. SWOT Analysis
Table 108. Plec Bioengineering Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product and Services
Table 109. Plec Bioengineering Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 110. Zoetis Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Type and Application
Table 111. Zoetis Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Major Business
Table 112. Zoetis Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Total Revenue (USD Million) (2018-2019)
Table 113. Zoetis SWOT Analysis
Table 114. Zoetis Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product and Services
Table 115. Zoetis Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 116. Bioveta Basic Information, Manufacturing Base and Competitors
Table 117. Bioveta Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Major Business
Table 118. Bioveta Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Total Revenue (USD Million) (2018-2019)
Table 119. Bioveta SWOT Analysis
Table 120. Bioveta Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product and Services
Table 121. Bioveta Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 122. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Manufacturer (2018-2019) (K Units)
Table 123. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Manufacturer (2018-2019) (USD Million)
Table 124. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Regions (2015-2020) (K Units)
Table 125. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Regions (2015-2020)
Table 126. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Regions (2015-2020) (USD Million)
Table 127. North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Countries (2015-2020) (K Units)
Table 128. North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Countries (2015-2020)
Table 129. North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Countries (2015-2020) (USD Million)
Table 130. North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Countries (2015-2020)
Table 131. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Countries (2015-2020) (K Units)
Table 132. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Countries (2015-2020)
Table 133. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Countries (2015-2020) (USD Million)
Table 134. Asia-Pacific Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Regions (2015-2020) (K Units)
Table 135. Asia-Pacific Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Regions (2015-2020)
Table 136. Asia-Pacific Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Regions (2015-2020) (USD Million)
Table 137. South America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Countries (2015-2020) (K Units)
Table 138. South America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Countries (2015-2020)
Table 139. South America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Countries (2015-2020) (USD Million)
Table 140. South America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Countries (2015-2020)
Table 141. Middle East & Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Countries (2015-2020) (K Units)
Table 142. Middle East & Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Countries (2015-2020)
Table 143. Middle East & Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Countries (2015-2020) (USD Million)
Table 144. Middle East & Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Countries (2015-2020)
Table 145. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Type (2015-2020) (K Units)
Table 146. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Share by Type (2015-2020)
Table 147. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Type (2015-2020) (USD Million)
Table 148. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Share by Type (2015-2020)
Table 149. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Application (2015-2020) (K Units)
Table 150. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Share by Application (2015-2020)
Table 151. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Forecast by Regions (2021-2025) (K Units)
Table 152. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Share Forecast by Regions (2021-2025)
Table 153. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Forecast by Type (2021-2025) (K Units)
Table 154. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Share Forecast by Type (2021-2025)
Table 155. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Forecast by Application (2021-2025)
Table 156. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Share Forecast by Application (2021-2025)
Table 157. Direct Channel Pros & Cons
Table 158. Indirect Channel Pros & Cons
Table 159. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Picture
Figure 2. Global Sales Market Share of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) by Type in 2019
Figure 3. Live Vaccine Picture
Figure 4. Inactivated Vaccine Picture
Figure 5. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Application in 2018
Figure 6. Government Tender Picture
Figure 7. Marketing Picture
Figure 8. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Status and Outlook (2015-2025) (USD Million)
Figure 9. United States Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue (Value) and Growth Rate (2015-2025)
Figure 10. Canada Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue (Value) and Growth Rate (2015-2025)
Figure 11. Mexico Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Germany Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue (Value) and Growth Rate (2015-2025)
Figure 13. France Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue (Value) and Growth Rate (2015-2025)
Figure 14. UK Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Russia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Italy Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue (Value) and Growth Rate (2015-2025)
Figure 17. China Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Japan Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Korea Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue (Value) and Growth Rate (2015-2025)
Figure 20. India Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Southeast Asia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Australia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 23. Brazil Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Egypt Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Saudi Arabia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue (Value) and Growth Rate (2015-2025)
Figure 26. South Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Turkey Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Manufacturer in 2019
Figure 29. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Manufacturer in 2019
Figure 30. Top 3 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Manufacturer (Revenue) Market Share in 2019
Figure 31. Top 6 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Manufacturer (Revenue) Market Share in 2019
Figure 32. Key Manufacturer Market Share Trend
Figure 33. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales and Growth Rate (2015-2020) (K Units)
Figure 34. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue and Growth Rate (2015-2020) (USD Million)
Figure 35. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Regions (2015-2020)
Figure 36. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Regions in 2018
Figure 37. North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales and Growth Rate (2015-2020)
Figure 38. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales and Growth Rate (2015-2020)
Figure 39. Asia-Pacific Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales and Growth Rate (2015-2020)
Figure 40. South America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales and Growth Rate (2015-2020)
Figure 41. Middle East & Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales and Growth Rate (2015-2020)
Figure 42. North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue and Growth Rate (2015-2020) (USD Million)
Figure 43. North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Countries (2015-2020)
Figure 44. North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Countries in 2018
Figure 45. North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 46. North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Countries in 2018
Figure 47. United States Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales and Growth Rate (2015-2020) (K Units)
Figure 48. Canada Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales and Growth Rate (2015-2020) (K Units)
Figure 49. Mexico Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales and Growth Rate (2015-2020) (K Units)
Figure 50. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue and Growth Rate (2015-2020) (USD Million)
Figure 51. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Countries (2015-2020)
Figure 52. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Countries in 2019
Figure 53. Germany Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales and Growth Rate (2015-2020) (K Units)
Figure 54. UK Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales and Growth Rate (2015-2020) (K Units)
Figure 55. France Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales and Growth Rate (2015-2020) (K Units)
Figure 56. Russia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales and Growth Rate (2015-2020) (K Units)
Figure 57. Italy Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales and Growth Rate (2015-2020) (K Units)
Figure 58. Asia-Pacific Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue and Growth Rate (2015-2020) (USD Million)
Figure 59. Asia-Pacific Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Regions 2019
Figure 60. Asia-Pacific Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Regions 2019
Figure 61. China Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales and Growth Rate (2015-2020) (K Units)
Figure 62. Japan Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales and Growth Rate (2015-2020) (K Units)
Figure 63. Korea Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales and Growth Rate (2015-2020) (K Units)
Figure 64. India Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales and Growth Rate (2015-2020) (K Units)
Figure 65. Southeast Asia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales and Growth Rate (2015-2020) (K Units)
Figure 66. South America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue and Growth Rate (2015-2020) (USD Million)
Figure 67. South America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Countries in 2019
Figure 68. South America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Countries in 2019
Figure 69. Brazil Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales and Growth Rate (2015-2020) (K Units)
Figure 70. Argentina Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales and Growth Rate (2015-2020) (K Units)
Figure 71. Middle East and Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue and Growth Rate (2015-2020) (USD Million)
Figure 72. Middle East and Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Countries in 2019
Figure 73. Middle East and Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Countries (2015-2020)
Figure 74. Middle East and Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Countries in 2019
Figure 75. Saudi Arabia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales and Growth Rate (2015-2020) (K Units)
Figure 76. Egypt Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales and Growth Rate (2015-2020) (K Units)
Figure 77. Turkey Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales and Growth Rate (2015-2020) (K Units)
Figure 78. South Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales and Growth Rate (2015-2020) (K Units)
Figure 79. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales and Growth Rate (2021-2025) (K Units)
Figure 80. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue and Growth Rate (2021-2025) (USD Million)
Figure 81. North America Sales Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Forecast (2021-2025) (K Units)
Figure 82. Europe Sales Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Forecast (2021-2025) (K Units)
Figure 83. Asia-Pacific Sales Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Forecast (2021-2025) (K Units)
Figure 84. South America Sales Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Forecast (2021-2025) (K Units)
Figure 85. Middle East & Africa Sales Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Forecast (2021-2025) (K Units)
Figure 86. Sales Channel: Direct Channel vs Indirect Channel
動物ワクチンの世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Animal Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Animal Vaccine market report p…- エボラワクチンの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The Ebola Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade r…
- 出血熱ワクチンの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The Hemorrhagic Fever Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizat…
- ヒトロタウイルスワクチンの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Human Rotavirus Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 6.0% in the forecast period of 2020 to 2025 and will expected to reach USD 8763 million by 2025, from USD 6949.3 million in 2019. The Human Rotaviru…
- 新型コロナウイルス感染症不活化ワクチンの世界市場2020年：企業別、地域別、種類・用途別 Market Overview The COVID-19 Inactivated Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimi…